In silico repurposing of antipsychotic drugs for Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is the most prevalent form of dementia and represents one of the highest unmet requirements in medicine today. There is shortage of novel molecules entering into market because of poor pharmacokinetic properties and safety issues. Drug repurposing offers an oppor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Shivani, Chowdhury, Suman, Kumar, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660441/
https://www.ncbi.nlm.nih.gov/pubmed/29078760
http://dx.doi.org/10.1186/s12868-017-0394-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660441/
https://www.ncbi.nlm.nih.gov/pubmed/29078760
http://dx.doi.org/10.1186/s12868-017-0394-8

Ejemplares similares